Related content

Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients

By Roussel V.   Yi F.   Jauberteau M.O.   Couderq C.   Lacombe C.   Michelet V.   Gil R.   Couratier P.   Vallat J.M.   Preud’homme J.L.  

Journal of Autoimmunity, Vol. 14, Iss. 3, 2000-05 ,pp. : 259-265

Academic Press

Access to resources Recommend Favorite

Interferon Beta in Multiple Sclerosis

By Arnason B.G.W.  

Clinical Immunology, Vol. 81, Iss. 1, 1996-10 ,pp. : 1-11

Academic Press

Access to resources Recommend Favorite

Serum Anti-cholesterol Antibodies in Chronic Hepatitis-C Patients During IFN-α-2b Treatment

By Bíró Adrienn   Horváth Anna   Varga Lilian   Nemesánszky Elemér   Csepregi Antal   Dávid Károly   Tolvaj Gyula   Ibrányi Endre   Telegdy László   Pár Alajos   Romics László   Karádi István   Horányi Margit   Gervain Judit   Ribiczey Pál   Csöndes Mihály   Füst George  

Immunobiology, Vol. 207, Iss. 3, 2003-05 ,pp. : 161-168

Urban & Fischer

Access to resources Recommend Favorite

Correlation Between Interferon Production and Clinical Disease Activity in Patients with Multiple Sclerosis

By Dettke M.   Scheidt P.   Prange H.   Kirchner H.  

Journal of Clinical Immunology, Vol. 17, Iss. 4, 1997-07 ,pp. : 293-300

Springer Publishing Company

Access to resources Recommend Favorite

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders

By Reindl M.   Khantane S.   Ehling R.   Schanda K.   Lutterotti A.   Brinkhoff C.   Oertle T.   Schwab M.E.   Deisenhammer F.   Berger T.   Bandtlow C.E.  

Journal of Neuroimmunology, Vol. 145, Iss. 1, 2003-12 ,pp. : 139-147

Elsevier

Access to resources Recommend Favorite